Switzerland-based Biogen has sued generic drug maker MSN Laboratories for allegedly threatening to infringe the patent for its top-selling oral MS drug Tecfidera.
King & Wood Mallesons senior associate Luke Hawthorne lives to roll up his sleeves and delve into the “weird and wonderful” technologies behind the patent cases he works on.
A top intellectual property barrister who has worked on cutting-edge cases that raise novel questions about the patentability of inventions has been appointed to the Federal Court.
Boxing champion Mike Tyson has sued Australian streetwear company Culture Kings for allegedly selling ‘misleading’ T-shirts featuring his image.
Chevron has mostly failed in its lawsuit accusing Australian petrol station company Ampol of infringing its Caltex trade marks, with a judge finding that Chevron’s case sought exclusive use over the colour red and was “at odds with commercial sense”.
A judge has thrown out trade mark infringement claims brought by AGL against Greenpeace for using the energy company’s logo in a public campaign labelling it “Australia’s biggest climate polluter”.
The Beatles hit producer EMI has lost its “ambitious” opposition to Australian craft company Spotlight registering ‘Abbey Road’ as a trade mark for its yarn products.
Kraft has agreed to pay Bega $9.25 million as part of a settlement resolving a long-running battle over peanut butter trade dress rights, after the US consumer goods giant exhausted all its options for appealing a ruling that found Bega had acquired the rights to the trade dress.
A judge has given Generic Health more time to file its evidence in a multimillion-dollar dispute with drug makers Otsuka and Bristol-Myers Squibbs over the delayed launch of generic versions of their antipsychotic drug Abilify, but warned there had to be a cut-off point for preparing the decade-long dispute for trial.
Furniture retailer Nick Scali Ltd must respond to subpeonas served by law firm Sparke Helmore seeking files held by the company’s new firm, Allens, in a case over $500,000 in unpaid fees that alleges CEO Anthony Scali knowingly gave false instructions to his solicitors.